These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 37814641

  • 1. The Ratio of Contrast Volume/Glomerular Filtration Rate and Urine NGAL Predicts the Progression of Acute Kidney Injury to Chronic Kidney Disease in Patients After Planned Percutaneous Coronary Intervention.
    Nguyen Duy T, Dao Bui Quy Q, Nguyen Duc L, Ho Viet Le D, Le Ha K, Do Gia T, Nguyen Trung K, Nguyen Van T, Nguyen Oanh O, Le Viet T.
    Int J Gen Med; 2023; 16():4525-4535. PubMed ID: 37814641
    [Abstract] [Full Text] [Related]

  • 2. Urinary neutrophil gelatinase-associated lipocalin predicted to contrast-associated acute kidney injury after planned percutaneous coronary intervention in elderly patients.
    Nguyen Duy T, Dao Bui Quy Q, Ho Viet Le D, Le Ha K, Nguyen Huu D, Nguyen Trung K, Tran Van D, Nguyen Oanh O, Luong Cong T, Tran Duc H, Le Viet T.
    J Clin Lab Anal; 2022 Dec; 36(12):e24757. PubMed ID: 36357318
    [Abstract] [Full Text] [Related]

  • 3. Urinary Neutrophil Gelatinase-Associated Lipocalin predicts the severity of contrast-induced acute kidney injury in chronic kidney disease patients undergoing elective coronary procedures.
    Tasanarong A, Hutayanon P, Piyayotai D.
    BMC Nephrol; 2013 Dec 05; 14():270. PubMed ID: 24305547
    [Abstract] [Full Text] [Related]

  • 4. Serum and Urine Neutrophil Gelatinase-Associated Lipocalin Levels Measured at Admission Predict Progression to Chronic Kidney Disease in Sepsis-Associated Acute Kidney Injury Patients.
    Tuan PNH, Quyen DBQ, Van Khoa H, Loc ND, Van My P, Dung NH, Toan ND, Quyet D, Thang LV.
    Dis Markers; 2020 Dec 05; 2020():8883404. PubMed ID: 32908617
    [Abstract] [Full Text] [Related]

  • 5. Value of urine/serum Neutrophil gelatinase-associated lipocalin ratio in distinguishing acute kidney injury from chronic kidney disease.
    Huang Z, Wu L, Zeng M, Wu B, Xu X, Mao H, Yuan Y, Xing C.
    Clin Chim Acta; 2022 Feb 01; 526():23-29. PubMed ID: 34958753
    [Abstract] [Full Text] [Related]

  • 6. Relation of Baseline Neutrophil Gelatinase-Associated Lipocalin (NGAL) Levels and Contrast-Induced Nephropathy following Percutaneous Coronary Intervention among Chronic Kidney Disease Patients.
    Lupu L, Abukatash H, Banai A, Rozenfeld KL, Lewit D, Merdler I, Loewenstein I, Bornstein G, Banai S, Shacham Y.
    J Clin Med; 2021 Nov 19; 10(22):. PubMed ID: 34830685
    [Abstract] [Full Text] [Related]

  • 7. Neutrophil gelatinase-associated lipocalin (NGAL) for the early detection of contrast-induced nephropathy after percutaneous coronary intervention.
    Liebetrau C, Gaede L, Doerr O, Blumenstein J, Rixe J, Teichert O, Willmer M, Weber M, Rolf A, Möllmann H, Hamm C, Nef H.
    Scand J Clin Lab Invest; 2014 Mar 19; 74(2):81-8. PubMed ID: 24304491
    [Abstract] [Full Text] [Related]

  • 8. Shrunken Pore Syndrome: A New and More Powerful Phenotype of Renal Dysfunction Than Chronic Kidney Disease for Predicting Contrast-Associated Acute Kidney Injury.
    Zhang LW, Luo MQ, Xie XW, You ZB, Zeng JL, Lin MQ, Chen LC, Lin KY, Guo YS.
    J Am Heart Assoc; 2023 Jan 03; 12(1):e027980. PubMed ID: 36565177
    [Abstract] [Full Text] [Related]

  • 9. Neutrophil Gelatinase-Associated Lipocalin as an Early Marker of Contrast-Induced Nephropathy After Elective Invasive Cardiac Procedures.
    Kafkas N, Liakos C, Zoubouloglou F, Dagadaki O, Dragasis S, Makris K.
    Clin Cardiol; 2016 Aug 03; 39(8):464-70. PubMed ID: 27175937
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of Urinary NGAL as a Diagnostic Tool for Acute Kidney Injury in Critically Ill Patients With Infection: An Original Study.
    Gomes BC, Silva Júnior JM, Tuon FF.
    Can J Kidney Health Dis; 2020 Aug 03; 7():2054358120934215. PubMed ID: 32612844
    [Abstract] [Full Text] [Related]

  • 11. Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study.
    Akrawinthawong K, Ricci J, Cannon L, Dixon S, Kupfer K, Stivers D, Alexander P, David S, McCullough PA.
    Ren Fail; 2015 Mar 03; 37(2):187-91. PubMed ID: 25519207
    [Abstract] [Full Text] [Related]

  • 12. Preventive Effect of Trimetazidine on Contrast-Induced Acute Kidney Injury in CKD Patients Based on Urinary Neutrophil Gelatinase-associated Lipocalin (uNGAL): A randomized Clinical Trial.
    Mirhosseni A, Farahani B, Gandomi-Mohammadabadi A, Keyvani H, Biglari-Abhari M, Davari A, Vazirizade-Mahabadi MH, Savaj S.
    Iran J Kidney Dis; 2019 May 03; 13(3):191-197. PubMed ID: 31209192
    [Abstract] [Full Text] [Related]

  • 13. Serial urinary neutrophil gelatinase associated lipocalin in pediatric diabetic ketoacidosis with acute kidney injury.
    Williams V, Jayashree M, Nallasamy K, Dayal D, Rawat A, Attri SV.
    Clin Diabetes Endocrinol; 2021 Nov 01; 7(1):20. PubMed ID: 34719396
    [Abstract] [Full Text] [Related]

  • 14. Neutrophil gelatinase-associated lipocalin (NGAL) for the prediction of acute kidney injury in chronic kidney disease patients treated with primary percutaneous coronary intervention.
    Banai A, Rozenfeld KL, Levit D, Merdler I, Loewenstein I, Banai S, Shacham Y.
    Int J Cardiol Heart Vasc; 2021 Feb 01; 32():100695. PubMed ID: 33364336
    [Abstract] [Full Text] [Related]

  • 15. Serial Measurements of Neutrophil Gelatinase-Associated Lipocalin levels for Assessment of Contrast Induced Nephropathy among Chronic Kidney Disease Patients Who Underwent Elective Coronary Angiography.
    Merdler I, Katas H, Banai A, Rozenfeld KL, Lewit D, Loewenstein I, Bornstein G, Banai S, Shacham Y.
    Isr Med Assoc J; 2023 May 01; 25(5):341-345. PubMed ID: 37245099
    [Abstract] [Full Text] [Related]

  • 16. Serum and Urinary NGAL and Cystatin C Levels as Diagnostic Tools for Acute Kidney Injury and Chronic Kidney Disease: A Histobiochemical Comparative Study.
    Sinna MM, Altaf FMN, Mosa OF.
    Curr Pharm Des; 2019 May 01; 25(10):1122-1133. PubMed ID: 31096894
    [Abstract] [Full Text] [Related]

  • 17. Is It Safe to Do Percutaneous Coronary Intervention in Moderate to Severe Chronic Kidney Disease Patients? A Prospective Cohort Study.
    Santosa Y, Harca AD, Yuwono A, Hermanto A, Oliver MS, Sukmadja E, Soewardi R.
    Cureus; 2022 Oct 01; 14(10):e30312. PubMed ID: 36407165
    [Abstract] [Full Text] [Related]

  • 18. Neutrophil gelatinase--associated lipocalin predicts acute kidney injury in patients undergoing liver transplantation.
    Portal AJ, McPhail MJ, Bruce M, Coltart I, Slack A, Sherwood R, Heaton ND, Shawcross D, Wendon JA, Heneghan MA.
    Liver Transpl; 2010 Nov 01; 16(11):1257-66. PubMed ID: 21031541
    [Abstract] [Full Text] [Related]

  • 19. The efficacy of biomarkers in the diagnosis of acute kidney injury secondary to liver cirrhosis.
    Yang Y, Ge B, Liu Y, Feng J.
    Medicine (Baltimore); 2021 Apr 09; 100(14):e25411. PubMed ID: 33832138
    [Abstract] [Full Text] [Related]

  • 20. Systemic reserve dysfunction and contrast-associated acute kidney injury following percutaneous coronary intervention.
    Kim MJ, Jeon DS, Ahn Y, Byeon J, Lee D, Choi IJ.
    PLoS One; 2024 Apr 09; 19(3):e0299899. PubMed ID: 38442122
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.